Meng-lun Lu
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 01, 2025
Construction of hot tumor classification models in gastrointestinal cancers.
Journal: Journal of translational medicine
Published: November 18, 2024
RAB31 drives extracellular vesicle fusion and cancer-associated fibroblast formation leading to oxaliplatin resistance in colorectal cancer.
Journal: Journal of extracellular biology
Published: September 21, 2023
A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer.
Journal: Neoplasia (New York, N.Y.)
Published: August 29, 2022
Rapid Control of a SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Community Outbreak: The Successful Experience in Pingtung County of Taiwan.
Journal: International journal of environmental research and public health
Published: December 23, 2021
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: March 03, 2020
Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response.
Journal: Clinical & translational immunology
Published: February 10, 2020
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Journal: The oncologist
Published: March 01, 2019
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients.
Journal: Oncotarget
Published: June 22, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026